Frontiers in Endocrinology (Oct 2022)
Editorial: Polycystic ovary syndrome (PCOS): Mechanism and management
- Yishu Wang,
- Yishu Wang,
- Yishu Wang,
- Peter Leung,
- Rong Li,
- Rong Li,
- Yanting Wu,
- Yanting Wu,
- Yanting Wu,
- Hefeng Huang,
- Hefeng Huang,
- Hefeng Huang
Affiliations
- Yishu Wang
- International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
- Yishu Wang
- Obstetrics and Gynecology Hospital, Institute of Reproduction and Development, Fudan University, Shanghai, China
- Yishu Wang
- Shanghai Key Laboratory of Embryo Original Diseases, Shanghai, China
- Peter Leung
- Department of Obstetrics and Gynaecology, BC Children’s Hospital Research Institute, University of British Columbia, Vancouver, BC, Canada
- Rong Li
- Centre for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China
- Rong Li
- National Clinical Research Centre for Obstetrics and Gynecology, Beijing, China
- Yanting Wu
- Obstetrics and Gynecology Hospital, Institute of Reproduction and Development, Fudan University, Shanghai, China
- Yanting Wu
- Shanghai Key Laboratory of Embryo Original Diseases, Shanghai, China
- Yanting Wu
- Research Units of Embryo Original Diseases, Chinese Academy of Medical Sciences, Shanghai, China
- Hefeng Huang
- Obstetrics and Gynecology Hospital, Institute of Reproduction and Development, Fudan University, Shanghai, China
- Hefeng Huang
- Shanghai Key Laboratory of Embryo Original Diseases, Shanghai, China
- Hefeng Huang
- Research Units of Embryo Original Diseases, Chinese Academy of Medical Sciences, Shanghai, China
- DOI
- https://doi.org/10.3389/fendo.2022.1030353
- Journal volume & issue
-
Vol. 13
Abstract
No abstracts available.Keywords
- Polycystic Ovary Syndrome (PCOS)
- pathophysiology, diagnosis
- prevention
- obstetrical complications
- offspring health
- clinical management, microbiome
